Multi-Point Potency Assay for Therapeutic Cell Compositions
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for determining the potency of therapeutic cell compositions, such as those expressing recombinant receptors for cell therapy, provide a one-dimensional view and fail to capture sensitivity to antigen stimulation, lacking the ability to distinguish between different therapeutic cell compositions due to variability in donors, production processes, and receptor types.
Innovation Solution
A method involving a series of incubations with varying titrated ratios of cells to a recombinant receptor stimulating agent to measure recombinant receptor-dependent activity, allowing for the determination of half-maximal activity and relative potency comparison across different cell compositions.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If a single-point potency assay is used, then the method is simple and quick, but it fails to capture sensitivity to antigen stimulation and cannot distinguish between different therapeutic cell compositions
Solution Approach 1:
The assay is segmented into multiple discrete steps: (1) incubating test cells with a first amount of stimulating agent, (2) measuring first signal output, (3) incubating the same cells with a second amount of stimulating agent, and (4) measuring second signal output. This segmentation allows the assay to capture sensitivity information at multiple stimulation levels, improving potency assessment accuracy while maintaining a manageable procedural complexity
Solution Approach 2:
The invention adds a temporal dimension to the potency assay by measuring signal output at multiple time points or stimulation levels rather than at a single point. This transforms the assay from a one-dimensional snapshot to a multi-dimensional assessment that captures the dynamic response of therapeutic cells to varying antigen stimulation, enabling differentiation between cell compositions with similar single-point readings
2Reliability
If variability in donors, production processes, and receptor types is accounted for, then the potency assessment becomes more comprehensive, but the assessment complexity increases
Solution Approach 1:
The multi-point assay protocol serves multiple functions simultaneously: it assesses baseline potency, measures sensitivity to antigen stimulation, enables comparison across different donors and production processes, and provides data for calculating relative potency. This universal approach handles variability in donors, production processes, and receptor types through a single integrated methodology, improving reliability without requiring separate assessment systems for each variable
Solution Approach 2:
The invention changes the stimulation parameter (amount of recombinant receptor stimulating agent) to multiple discrete levels rather than using a fixed amount. By measuring cell response at different stimulation intensities, the assay can distinguish between cell compositions that may have similar baseline activity but differ in their sensitivity or responsiveness to antigen stimulation, thereby accounting for variability across donors and production processes
3Loss of information
If multiple titrated ratios are tested, then sensitivity to antigen stimulation is captured, but the time and resources required for the assay increase
Solution Approach 1:
The assay uses a predetermined protocol where the amounts of stimulating agent for the first and second incubations are established in advance based on expected sensitivity ranges. This preliminary design allows the assay to capture sensitivity information efficiently without requiring extensive optimization or exploration during execution, reducing the time and resources needed while still obtaining comprehensive sensitivity data
Solution Approach 2:
The invention uses the same cell sample for both the first and second incubations, copying the cellular material rather than requiring separate cell preparations. This approach eliminates the need to culture and prepare duplicate cell populations, significantly reducing assay time and resources while still obtaining comparative sensitivity measurements from the identical cell population under different stimulation conditions
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach provides a more comprehensive assessment of therapeutic cell composition potency, enabling improved manufacturing control, stability, and safety by accounting for variability in donor sources and production processes, and allowing for the comparison of different cell products.
Implementation Method 1
binding of the recombinant receptor stimulating agent to the recombinant receptor stimulates a recombinant receptor-dependent activity in the cell
Data Source
AI summary
The present disclosure relates to methods of determining potency of a therapeutic cell compositions in connection with cell therapy. The cells of the therapeutic cell composition can express recombinant receptors such as chimeric receptors, e.g., chimeric antigen receptors (CARs) or other transgenic receptors such as T cell receptors (TCRs). The methods provide an assay for identifying the potency, including relative potency, of a therapeutic cell composition.